This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Brandenburgische Technische Universität Cottbus-Senftenberg, Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Ga Generic Assays Gmbh. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: Alexey Elimport: Innovator in Biomarker Evaluation
Introduction
Alexey Elimport is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biomedical engineering, particularly in the evaluation of biomarkers in tissue samples. His innovative approach combines advanced imaging techniques with computer-assisted analysis.
Latest Patents
Elimport holds a patent for a "Method, system and computer program for computer-assisted evaluation of biomarkers in a tissue sample." This patent discloses a method that includes several steps: providing an image of the tissue sample, automatically determining blood vessel probabilities, identifying assumed blood vessel locations, selecting biomarkers outside these locations, and evaluating the selected biomarkers. This method enhances the accuracy and efficiency of biomarker evaluation, which is crucial for medical diagnostics.
Career Highlights
Throughout his career, Alexey Elimport has worked with prestigious institutions such as the Deutsches Krebsforschungszentrum (German Cancer Research Center) and Brandenburgische Technische Universität Cottbus-Senftenberg. His work in these organizations has allowed him to develop and refine his innovative methods for biomarker evaluation.
Collaborations
Elimport has collaborated with several professionals in his field, including Cläre Von Neubeck and Rico Hiemann. These collaborations have contributed to the advancement of his research and the successful implementation of his patented methods.
Conclusion
Alexey Elimport's contributions to the field of biomarker evaluation through his innovative patent demonstrate his commitment to advancing medical technology. His work continues to impact the way tissue samples are analyzed, paving the way for improved diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile